Search research articles
Contact Us
Filters
Showing results (261-270 of 662) with videos related to
Page
of 67
Sort By:
Leukemia & Lymphoma
|
May 27, 2004
Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816V
Friedrich Wimazal, Josef Schwarzmeier, Karl Sotlar, et al.
Experimental Hematology
|
June 24, 2010
H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells
Emir Hadzijusufovic, Barbara Peter, Karoline V Gleixner, et al.
International Journal of Molecular Sciences
|
February 4, 2021
A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
Jan Romantowski, Aleksandra Górska, Marek Niedoszytko, et al.
Expert Review of Hematology
|
November 25, 2010
Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study
Francis J Giles, Gianantonio Rosti, Photis Beris, et al.
American Journal of Hematology
|
July 27, 2010
Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge
Angela R Arredondo, Jason Gotlib, Luke Shier, et al.
Leukemia & Lymphoma
|
August 31, 2017
A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1
Sonja Burgstaller, Reinhard Stauder, Thomas Kuehr, et al.
Human Pathology
|
May 2, 2008
Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease
Alexander W Hauswirth, Manuela Födinger, Marika Fritz, et al.
Oncotarget
|
March 6, 2013
STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia
Wolfgang Warsch, Eva Grundschober, Angelika Berger, et al.
In Vivo (Athens, Greece)
|
December 22, 2009
Chemotherapy in canine acute megakaryoblastic leukemia: a case report and review of the literature
Michael Willmann, Leonhard Müllauer, Ilse Schwendenwein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 9, 2007
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib
Oliver Hantschel, Uwe Rix, Uwe Schmidt, et al.
Page
of 67
Search research articles
Search
Showing results (261-270 of 662) with videos related to
Sort By:
Page
of 67
Leukemia & Lymphoma
|
May 27, 2004
Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816V
Friedrich Wimazal, Josef Schwarzmeier, Karl Sotlar, et al.
Experimental Hematology
|
June 24, 2010
H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells
Emir Hadzijusufovic, Barbara Peter, Karoline V Gleixner, et al.
International Journal of Molecular Sciences
|
February 4, 2021
A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
Jan Romantowski, Aleksandra Górska, Marek Niedoszytko, et al.
Expert Review of Hematology
|
November 25, 2010
Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study
Francis J Giles, Gianantonio Rosti, Photis Beris, et al.
American Journal of Hematology
|
July 27, 2010
Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge
Angela R Arredondo, Jason Gotlib, Luke Shier, et al.
Leukemia & Lymphoma
|
August 31, 2017
A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1
Sonja Burgstaller, Reinhard Stauder, Thomas Kuehr, et al.
Human Pathology
|
May 2, 2008
Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease
Alexander W Hauswirth, Manuela Födinger, Marika Fritz, et al.
Oncotarget
|
March 6, 2013
STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia
Wolfgang Warsch, Eva Grundschober, Angelika Berger, et al.
In Vivo (Athens, Greece)
|
December 22, 2009
Chemotherapy in canine acute megakaryoblastic leukemia: a case report and review of the literature
Michael Willmann, Leonhard Müllauer, Ilse Schwendenwein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 9, 2007
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib
Oliver Hantschel, Uwe Rix, Uwe Schmidt, et al.
Page
of 67